Minshall ME[au] - Search Results

Year	Number of Results
1993	1
1998	1
1999	1
2000	1
2001	1
2002	1
2003	1
2004	6
2005	2
2006	1
2007	2
2008	7
2009	6
2010	2
2015	1
2020	1
2023	1
2024	0

1

Budget impact analysis of a digital monitoring platform for COPD.

Inocencio TJ, Sterling KL, Sayiner S, Minshall ME, Kaye L, Hatipoğlu U. Inocencio TJ, et al. Among authors: minshall me. Cost Eff Resour Alloc. 2023 Jun 4;21(1):36. doi: 10.1186/s12962-023-00443-x. Cost Eff Resour Alloc. 2023. PMID: 37271821 Free PMC article.

2

Objective measurement in Parkinson's disease: a descriptive analysis of Parkinson's symptom scores from a large population of patients across the world using the Personal KinetiGraph®.

Pahwa R, Bergquist F, Horne M, Minshall ME. Pahwa R, et al. Among authors: minshall me. J Clin Mov Disord. 2020 Apr 30;7:5. doi: 10.1186/s40734-020-00087-6. eCollection 2020. J Clin Mov Disord. 2020. PMID: 32377368 Free PMC article.

3

Cost-utility analysis: the nirvana to health economists and an enigma to decision-makers?

Minshall ME. Minshall ME. Expert Rev Pharmacoecon Outcomes Res. 2002 Feb;2(1):3-5. doi: 10.1586/14737167.2.1.3. Expert Rev Pharmacoecon Outcomes Res. 2002. PMID: 19807422 No abstract available.

4

Are USA payers moving beyond pharmaceutical budget impact models and embracing cost-effectiveness analysis?

Minshall ME. Minshall ME. Expert Rev Pharmacoecon Outcomes Res. 2005 Dec;5(6):659-60. doi: 10.1586/14737167.5.6.659. Expert Rev Pharmacoecon Outcomes Res. 2005. PMID: 19807605 No abstract available.

5

Review of the pharmacoeconomic research on gemcitabine in the treatment of advanced non-small cell lung cancer.

Minshall ME, Liepa AM. Minshall ME, et al. Am J Manag Care. 1998 Nov;4(11):1591-602. Am J Manag Care. 1998. PMID: 10338905 Free article. Review.

6

Pioglitazone versus rosiglitazone treatment in patients with type 2 diabetes and dyslipidemia: cost-effectiveness in the US.

Tunis SL, Minshall ME, St Charles M, Pandya BJ, Baran RW. Tunis SL, et al. Among authors: minshall me. Curr Med Res Opin. 2008 Nov;24(11):3085-96. doi: 10.1185/03007990802434874. Epub 2008 Oct 2. Curr Med Res Opin. 2008. PMID: 18826750

7

Oleksik A, Lips P, Dawson A, Minshall ME, Shen W, Cooper C, Kanis J. Oleksik A, et al. Among authors: minshall me. J Bone Miner Res. 2000 Jul;15(7):1384-92. doi: 10.1359/jbmr.2000.15.7.1384. J Bone Miner Res. 2000. PMID: 10893688 Free article. Clinical Trial.

8

Validation of the CORE Diabetes Model against epidemiological and clinical studies.

Palmer AJ, Roze S, Valentine WJ, Minshall ME, Foos V, Lurati FM, Lammert M, Spinas GA. Palmer AJ, et al. Among authors: minshall me. Curr Med Res Opin. 2004 Aug;20 Suppl 1:S27-40. doi: 10.1185/030079904X2006. Curr Med Res Opin. 2004. PMID: 15324514

9

Long-term cost-effectiveness of pioglitazone versus placebo in addition to existing diabetes treatment: a US analysis based on PROactive.

Valentine WJ, Tucker D, Palmer AJ, Minshall ME, Foos V, Silberman C; PROactive Study Group. Valentine WJ, et al. Among authors: minshall me. Value Health. 2009 Jan-Feb;12(1):1-9. doi: 10.1111/j.1524-4733.2008.00403.x. Epub 2008 Jul 24. Value Health. 2009. PMID: 18657104 Free article.

10

Estimating the long-term cost-effectiveness of exenatide in the United States: an adjunctive treatment for type 2 diabetes mellitus.

Minshall ME, Oglesby AK, Wintle ME, Valentine WJ, Roze S, Palmer AJ. Minshall ME, et al. Value Health. 2008 Jan-Feb;11(1):22-33. doi: 10.1111/j.1524-4733.2007.00211.x. Value Health. 2008. PMID: 18237357 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

34 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Results by year